We would love to hear your thoughts about our site and services, please take our survey here.
Great post and sums up the attitude one should take towards aim shares.ie don't be greedy buy low sell high , take your profit as for the most part AIM shares are ''turkeys'', badly managed, open to market vagaries and manipulated by market markers etc
Hopefully scancell will prove the above rules wrong but time and again the turkeys win out and i for one have the battle scars to prove it
By way of distraction from the disappointing RNS drop over at redx i posted the following there and thought it might be worth doing the same here as a long term investor
it seems that any decent pharma company with a proven pipeline and some sort of income stream/partnerships on the AIM may eventiually be bought out assuming all goes to plan eg
Amryt formerly of Aim recently sold to Chiesi Farmaceutici,
Redx being aquired by Jounce
Diurnal bought by Neurocrine bio
vectura pharma by philip morris
Any thoughts on the next Aim Target bio or otherwise ? Scancell aside
As the initiator of this post and for fear of being called a ramper i will hold my fire for a post or two.
By way of distraction from the disappointing RNS drop
it seems that any decent pharma company with a proven pipeline and some sort of income stream/partnerships on the AIM will eventiually be bought out eg
Amryt formerly of Aim recently sold to Chiesi Farmaceutici,
Redx being aquired by Jounce
Diurnal bought by Neurocrine bio
vectura pharma by philip morris
Any thoughts on the next Aim Target bio or otherwise ?
As the initiator of this post and for fear of being called a ramper i will hold my fire for a post or two.
Stop embarrassing yourself with all the ramping , at the very least put IMHO, DYOR
yes typical Aim but ''very'' typical Evg and i say that as someone invested here.
Fingers crossed it all means nothing in the overall scheme of things come trial results day
Good point Nolupus, this share has been very frustrating to say the least
Its all about lessons in this game and quicker learned the better , well said Hasiba